Tag: hepatitis b

Arbutus Biopharma Corporation NASDAQ ABUS Clinical Trials Phase 1a 1b

Arbutus Biopharma Corporation (NASDAQ: ABUS) Jumps 41% After Receiving Regulatory Approval to Launch Phase 1a/1b Clinical Trial of AB-729

by admin

June 20, 2019

Arbutus Biopharma Corporation (NASDAQ: ABUS) is engaged as a biopharmaceutical company that is focused on the research, development and commercialization ...

No Result

View All Result

Home
News
Video
Stock and Crypto Screener

Tag: hepatitis b

Arbutus Biopharma Corporation (NASDAQ: ABUS) Jumps 41% After Receiving Regulatory Approval to Launch Phase 1a/1b Clinical Trial of AB-729

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

A Beginner’s Guide to Quantum Computing: 5 Stocks to Watch in the Emerging Industry

Comparing Small Cap and Large Cap Stocks: Which is Right for Your Investment Portfolio?

Sonoma Pharmaceuticals (NASDAQ: SNOA) and EMC Pharma Receives DAPA Registration for Microcyn Rx Products from U.S. Department of Defense

How to Find Top-Tier Small-Cap Stocks

Recent News

A Beginner’s Guide to Quantum Computing: 5 Stocks to Watch in the Emerging Industry

Comparing Small Cap and Large Cap Stocks: Which is Right for Your Investment Portfolio?

Categories

Site Navigation